Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Prazosin |
EINECS | 242-885-8 |
CAS No. | 19216-56-9 | Density | 1.353 g/cm3 |
PSA | 106.95000 | LogP | 3.17070 |
Solubility | 3.2mg/L(22.5 oC) | Melting Point |
278-280°C |
Formula | C19H21N5O4 | Boiling Point | 638.366 °C at 760 mmHg |
Molecular Weight | 383.407 | Flash Point | 339.871 °C |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)- (9CI);Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)- (8CI);4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone;Furazosin;Lentopres; |
Article Data | 19 |
IUPAC Name: [4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone
The MF of Prazosin (CAS NO.19216-56-9) is C19H21N5O4.
The MW of Prazosin (CAS NO.19216-56-9) is 383.4.
Synonyms of Prazosin (CAS NO.19216-56-9): [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](furan-2-yl)methanone ; 1-(4-Amino-6, 7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)piperazine monohydrochloride
Apperance: Crystallization
Index of Refraction: 1.651
EINECS: 242-885-8
Density: 1.352 g/ml
Flash Point: 339.9 °C
Boiling Point: 638.4 °C
Melting Point: 278-280 °C
Prazosin (CAS NO.19216-56-9) is orally active and has a minimal effect on cardiac function due to its alpha-1 receptor selectivity.it is a second-line choice for the treatment of high blood pressure.Prazosin is also useful in treating urinary hesitancy associated with prostatic hyperplasia by blocking alpha-1 receptors, which control constriction of both the prostate and ureters.This medication has shown to be effective in treating severe nightmares in children, associated with PTSD symptoms.
3,4-Dimethoxy--6-amino-benzonitrile generated 3,4-dimethoxy-6-Thiocyanate acyl benzonitrile in water and dichloromethane and sulfur anal phosgene (yield is 94% ).It would get thiourea derivative by reacted with 1-(2-furan-carbonyl)-piperazine in ethyl acetate(yield is 90%). Then derived free S-methyl-isothiourea derivatives by methylated with methyl iodide to the reaction with the alkali treatment(yield is 95%). Finally,formamide prazosin was gotten by the reaction of S-methyl isothiourea biological, ammonia, ammonium chloride and urea.
1. | orl-wmn TDLo:20 µg/kg:BPR,GIT | AIMEAS Annals of Internal Medicine. 97 (1982),455. | ||
2. | orl-man TDLo:1143 µg/kg:BPR | AMSVAZ Acta Medica Scandinavica. 213 (1983),157. | ||
3. | orl-hmn TDLo:280 µg/kg:CNS,CVS | BMJOAE British Medical Journal. 2 (1976),508. | ||
4. | orl-hmn TDLo:1260 µg/kg:CNS,KID | BMJOAE British Medical Journal. 1 (1978),622. |
Human systemic effects by ingestion of very small amounts: somnolence, hallucinations, distorted perceptions, changes in motor activity, decreased blood pressure, nausea or vomiting, and kidney effects. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.
Prazosin is a sympatholytic drug used to treat high blood pressure (hypertension). It belongs to the class of alpha-adrenergic blockers, which lower blood pressure by relaxing blood vessels. Specifically, prazosin is selective for the alpha-1 receptors on vascular smooth muscle. These receptors are responsible for the vasoconstrictive action of norepinephrine, which would normally raise blood pressure. By blocking these receptors, prazosin reduces blood pressure.